Alkermes
oncology goal activate innate and adaptive immune responses to drive tumor cell death antigen identification and presentation recognition by immune system immune system activation endogenous other immune cell mediated tumor cell death dendritic cell presenting antigen activated cells and cells activated cells attacking tumor tumor killing and release of antigens cells cells aes | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
85 of 144
Similar slides by Alkermes
See diffirences between slides (animation)
Investor Day
March 2021
oncology goal activate innate and adaptive immune responses to drive tumor cell death enhanced antigen identification and presentation cell death amplified immune system activation enhanced immune cell mediated tumor cell death chemotherapy radiation inhibitors targeted agents growth factor inhibitors dendritic cell presenting antigen activation and expansion cells and cells activated cells attacking tumor tumor killing and release of antigens cells cells | Alkermes
Investor Day
March 2021
oncology goal activate innate and adaptive immune responses to drive tumor cell death antigen identification and presentation amplified immune system activation immune cell mediated tumor cell death recognition by immune system dendritic cell presenting antigen activation and expansion cells and cells activated cells attacking tumor tumor killing and release of antigens cells cells | Alkermes
Investor Day
March 2021
oncology goal activate innate and adaptive immune responses to drive tumor cell death enhanced antigen identification and presentation cell death chemotherapy radiation inhibitors targeted agents growth factor inhibitors immune system activation endogenous other immune cell mediated tumor cell death dendritic cell presenting antigen activated cells and cells activated cells attacking tumor tumor killing and release of antigens cells cells aes | Alkermes
Related slides by other companies
Enochian Biosciences
Investor Presentation
January 2024
tumor cells can evade normal immune response | Enochian Biosciences
Cytek
Investor Day
June 2022
immune system is known to be incredibly complex but you would never suspect that if you look at the immune cells under the microscope | Cytek
SentiBio
SPAC
October 2021
senti discovered as a safety antigen that is highly expressed in healthy epithelial cells but not in tumor cells | SentiBio
Enochian Biosciences
Investor Presentation
January 2024
cell and gene platforms engineered dendritic cell therapeutic vaccine solid tumors engineered cell therapeutic vaccine | Enochian Biosciences
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io